MitoCareX Bio adds bioinformatician to expand disease-pathway analysis Oct 12, 2026 08:07AM
MitoCareX Bio moves drug discovery computing to Google Cloud Oct 7, 2026 07:32AM
MitoCareX Bio begins early-stage review of protein sourcing methods Sep 23, 2026 07:09AM
MitoCareX Bio selects SLC transport protein for drug discovery Jul 28, 2026 08:06AM
Nexentis Technologies (NXTS) files for 2.57M share offering by selling stockholders Jul 13, 2026 04:08PM


Jun 29, 2026 08:20AM Nexentis partially monetizes Melz solar project at $14.5M valuation
Jun 22, 2026 08:23AM MitoCareX Bio partners with Boltz on AI-driven SLC drug discovery
Jun 17, 2026 07:33AM MitoCareX Bio completes SLC transport protein structural analysis
May 18, 2026 09:34AM Nexentis unit achieves drug discovery milestone with improved molecule
May 18, 2026 09:31AM Nexentis subsidiary hits drug discovery milestone for cancer treatment
May 13, 2026 07:07AM Nexentis subsidiary achieves drug discovery milestone
May 5, 2026 07:32AM Nexentis receives U.S. trademark registration for MITOLINE algorithm
Apr 16, 2026 04:18PM Nexentis Technologies (NXTS) files $100M mixed shelf